Engineering Culture Platforms to Mimic Liver Diseases

Originally Aired: 16 May 2018

Already registered? Click here


Watch this webinar for an overview of complex models related to liver disease research, presented by Dr. Salman Khetani, Associate Professor for Bioegineering at University of Illinois at Chicago.

Dr. Salman Khetani discusses:

  • Drug discovery related to liver diseases
  • Methods for building advanced liver models
  • Emerging trends in liver disease research

You will learn about:
This webinar considers technologies being employed to build advanced human liver culture platforms that display key features of global liver diseases such as non-alcoholic fatty liver disease, liver fibrosis, and hepatitis B viral infection, which are currently the subject of novel drug discovery by several major pharmaceutical companies. The use of primary human hepatocytes and other cell types of the liver (e.g. hepatic stellate cells) for building human liver platforms is discussed as well as long-term cell characterization and drug validation data as appropriate. Finally, emerging trends are discussed that will move the field forward towards alleviating the burden of liver disease on human patient populations.

Presenter: Salman Khetani, Ph.D.
Associate Professor
University of Illinois at Chicago, Department of Bioengineering
View Biography
Moderator: Katherine Witt
Marketing Communications Specialist, ADMETox
Lonza Bioscience Solutions

Registration details:

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

(*) denotes required form field(s)